Bristol-Myers Squibb and Saladax Biomedical have announced that they have expanded their agreement covering the development and commercialization of diagnostic assays for the early detection of Alzhei… more →
Silico Researchwrote 4 months ago: The announcement that Johnson & Johnson may sell its $2.2 billion Ortho Clinical Diagnostics div … more →
wrote 1 year ago: Image via Wikipedia No Mortality Benefit Seen from PSA Screening By Charles Bankhead, Staff Wri … more →
wrote 1 year ago: Bristol-Myers Squibb and Saladax Biomedical have announced that they have expanded their agreement c … more →